Cargando…
Optimal echocardiographic assessment of myocardial dysfunction for arrhythmic risk stratification in phospholamban mutation carriers( )
AIMS : Phospholamban (PLN) p.Arg14del mutation carriers are at risk of developing malignant ventricular arrhythmias (VAs) and/or heart failure. Currently, left ventricular ejection fraction (LVEF) plays an important role in risk assessment for VA in these individuals. We aimed to study the increment...
Autores principales: | Taha, Karim, Verstraelen, Tom E, de Brouwer, Remco, de Bruin-Bon, Rianne H A C M, Cramer, Maarten J, Te Rijdt, Wouter P, Bouma, Berto J, de Boer, Rudolf A, Doevendans, Pieter A, Asselbergs, Folkert W, Wilde, Arthur A M, van den Berg, Maarten P, Teske, Arco J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9584619/ https://www.ncbi.nlm.nih.gov/pubmed/34516619 http://dx.doi.org/10.1093/ehjci/jeab178 |
Ejemplares similares
-
Early- and late anthracycline-induced cardiac dysfunction: echocardiographic characterization and response to heart failure therapy
por: Kamphuis, Janine A. M., et al.
Publicado: (2020) -
Deep neural network-based clustering of deformation curves reveals novel disease features in PLN pathogenic variant carriers
por: Taha, Karim, et al.
Publicado: (2023) -
Echocardiographic quantification of myocardial function using tissue deformation imaging, a guide to image acquisition and analysis using tissue Doppler and speckle tracking
por: Teske, Arco J, et al.
Publicado: (2007) -
Discovering and Visualizing Disease-Specific Electrocardiogram Features Using Deep Learning: Proof-of-Concept in Phospholamban Gene Mutation Carriers
por: van de Leur, Rutger R., et al.
Publicado: (2021) -
Cancer Therapy-Related Cardiac Dysfunction of Nonanthracycline Chemotherapeutics: What Is the Evidence?
por: Kamphuis, Janine A.M., et al.
Publicado: (2019)